Serum Institute buys 20% stake in US-based IntegriMedical

Serum Institute of India acquires 20% stake in IntegriMedical for N-FIS drug delivery solution. Adar Poonawalla envisions a needle-free vaccine administration. N-FIS has regulatory approvals and patented technology. Available in the Indian private market, it eliminates needle-phobia and prevents injuries.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/F7cgW2D
via IFTTT